# Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema

> **NCT00367133** · PHASE3 · COMPLETED · sponsor: **Jaeb Center for Health Research** · enrollment: 840 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **PROCEDURE:** Standard of Care Group
- **DRUG:** 1mg triamcinolone acetonide
- **DRUG:** 4mg triamcinolone acetonide

## Key facts

- **NCT ID:** NCT00367133
- **Lead sponsor:** Jaeb Center for Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2008-05
- **Final completion:** 2008-10
- **Target enrollment:** 840 (ACTUAL)
- **Last updated:** 2016-08-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00367133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00367133, "Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00367133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*